OTIS W. BRAWLEY - 31 Mar 2025 Form 4 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Role
Director
Signature
/s/ Matthew Lang, as Attorney-in-Fact
Issuer symbol
LYEL
Transactions as of
31 Mar 2025
Net transactions value
+$19,958
Form type
4
Filing time
02 Apr 2025, 15:46:01 UTC
Previous filing
18 Mar 2025
Next filing
19 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYEL Common Stock Purchase $19,958 +35,640 $0.5600 35,640 31 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.